Manila Times
GENEVA, Nov. 4, 2024 /PRNewswire/ -- Dukascopy Bank proudly celebrates 20 years of empowering traders and banking clients worldwide. 20 Years
Luxembourg - 4 November 2024 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced transactions made in accordance with its share repurchase
SINGAPORE, Nov. 4, 2024 /PRNewswire/ -- Xtend, a leading AI-powered digital marketing company, has announced record financial results for the first ha
Press ReleaseAtos Sust
SUZHOU, China, Nov. 4, 2024 /PRNewswire/ -- A new UN publication on using smart technologies to plan and build fair and sustainable cities will launch
Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3Through October more than 2,200 unique pre
ST HELIER, Jersey, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (NYSE AMERICAN, AIM and VFEX: CMCL) ("Caledonia" or the "Company
SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE: 688271), a global leader in manufacturing advanced medical imaging and radiothe
HANOI, Vietnam, Nov. 4, 2024 /PRNewswire/ -- October 31, 2024, Sungrow, the global leading PV inverter and energy storage system provider, retu
PRESS RELEASE Paris - November 4, 2024Bureau Veritas strengthens its Buildings & Infrastructure leadership position in Asia-Pacific with an agreement
MANILA, Philippines — Karl Eldrew Yulo led the way for the Philippine pre-junior and junior gymnasts 3rd JRC Artistic Gymnastics Championships in Ba
Sampo plc, stock exchange release, 4 November 2024 at 8:30 am EETSampo plc's share buybacks 1 November 2024On 1 November 2024, Sampo plc (business cod
BW Energy Limited - First day of trading of bondsReference is made to the stock exchange announcement by BW Energy Limited (the "Company") on 31 Octob
OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for
OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for
QIAstat-Dx Meningitis/Encephalitis Panel cleared in the U.S. for use in clinical settings to help diagnose central nervous system infections // Fourth
MANILA, Philippines — June Mar Fajardo's road to PBA immortality has long been a foregone conclusion. In fact, last Sunday's precedent-smashing 11
SHENZHEN, China, Nov. 4, 2024 /PRNewswire/ -- As the excitement for the upcoming 11.11 Singles' Day shopping festival builds, UGREEN, a global leader
Blackpanda and CSA will exchange intelligence to enhance their capabilities against cyber threats CSA joins Blackpanda's network of esteemed p
Arcadis reports transactions under its current share buyback program Amsterdam, November 4, 2024 - Arcadis (EURONEXT: ARCAD), the leading data driven
